Dauntless Investment Group, LLC Aquestive Therapeutics, Inc. Transaction History
Dauntless Investment Group, LLC
- $85.4 Billion
- Q1 2025
A detailed history of Dauntless Investment Group, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 91,540 shares of AQST stock, worth $215,119. This represents 0.31% of its overall portfolio holdings.
Number of Shares
91,540Holding current value
$215,119% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
129Shares Held
44.5MCall Options Held
44.6KPut Options Held
182K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$23.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$9.57 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.73MShares$8.76 Million0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$4 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $125M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...